NCT06639555View on ClinicalTrials.gov

Initial Clinical and CBCT Outcomes of Enamel Matrix Derivative-Based Regenerative Therapy in Vertical Bone Defects

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 24, 2022

Primary Completion Date

February 15, 2023

Study Completion Date

August 15, 2023

Conditions
Vertical Alveolar Bone Loss
Interventions
PROCEDURE

PRP( platelet rich plasma)

regenerative therapy with PRP for vertical bone defects

PROCEDURE

EMD (Enamel Matrix Derivative)

regenerative therapy with EMD for vertical bone defects

PROCEDURE

Guided Tissue Regeneration (barrier membrane)

guided tissue regeneration with barrier membrane alone for vertical bone defects

PROCEDURE

Guided Tissue Regeneration(barrier membrane and PRP)

guided tissue regeneration with barrier membrane and PRP for vertical bone defects

Trial Locations (1)

9000

Medical University - Varna, Varna

All Listed Sponsors
lead

Tsvetalina Gerova-Vatsova

OTHER